Safety and tolerability of cariprazine in patients with acute bipolar mania: pooled analysis of 3 phase II/III pivotal studies

被引：0
|
作者：
Yatham, L. N. [1 ]
Vieta, E. [2 ]
Lu, K. [3 ]
Nagy, K. [4 ]
Laszlovszky, I. [4 ]
Earley, W. [3 ]
Durgam, S. [3 ]
机构：
[1] Univ British Columbia, Dept Psychiat, Mood Disorders Clin Res Unit, Vancouver, BC, Canada
[2] Univ Barcelona, Dept Psychiat, Barcelona, Spain
[3] Forest Res Inst, Jersey City, NJ USA
[4] Gedeon Richter Plc, Budapest, Hungary
来源：
EUROPEAN NEUROPSYCHOPHARMACOLOGY | 2014年 / 24卷
关键词：
D O I：
10.1016/S0924-977X(14)70681-9
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P.2.d.023
引用
收藏
页码：S426 / S427
页数：2
相关论文
共 50 条
  • [41] Safety and tolerability of opicapone in the treatment of Parkinson's disease and motor fluctuations: Analysis of pooled phase III studies
    Ferreira, J.
    Lees, A.
    Gama, H.
    Lopes, N.
    Santos, A.
    Costa, R.
    Oliveira, C.
    Pinto, R.
    Nunes, T.
    Rocha, J. F.
    Soares-da-Silva, P.
    MOVEMENT DISORDERS, 2015, 30 : S86 - S86
  • [42] Safety and Tolerability of Opicapone in Patients with Parkinson's Disease and Motor Fluctuations: Pooled Analysis of Two Phase 3 Studies
    Kremens, D.
    Poewe, W.
    Rascol, O.
    Olson, K.
    Farahmand, K.
    Siegert, S.
    McMicken, C.
    Rocha, J. F.
    Soares-da-Silva, P.
    Liang, G. S.
    MOVEMENT DISORDERS, 2019, 34 : S8 - S8
  • [43] Efficacy and safety of low- and high-dose cariprazine in patients with acute mania associated with bipolar I disorder
    Calabrese, J. R.
    Keck, P. E., Jr.
    Starace, A.
    Lu, K.
    Ruth, A.
    Laszlovszky, I.
    Nemeth, G.
    Durgam, S.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2013, 23 : S378 - S379
  • [44] Efficacy and safety of low- and high-dose cariprazine in patients with acute mania associated with bipolar I disorder
    Calabrese, J. R.
    Keck, P. E.
    Lu, K.
    Laszlovszky, I.
    Starace, A.
    Nemeth, G.
    Durgam, S.
    BIPOLAR DISORDERS, 2013, 15 : 132 - 132
  • [45] Cariprazine in the treatment of acute mania in bipolar trial I disorder: A double-blind, placebo-controlled, Phase III
    Sachs, Gary S.
    Greenberg, William M.
    Starace, Anju
    Lu, Kaifeng
    Ruth, Adam
    Laszlovszky, Istvan
    Nemeth, Gyoergy
    Durgam, Suresh
    JOURNAL OF AFFECTIVE DISORDERS, 2015, 174 : 296 - 302
  • [46] Safety and tolerability of cariprazine in patients with acute manic or mixed episodes associated with bipolar I disorder: results from two phase-III, placebo-controlled trials
    Ketter, T.
    Lu, K.
    Debelle, M.
    Laszlovszky, I.
    Durgam, S.
    Earley, W.
    BIPOLAR DISORDERS, 2014, 16 : 93 - 93
  • [47] A Pooled Analysis of 3 Randomized, Placebo-Controlled, Phase 3 Studies Evaluating the Efficacy, Safety, and Tolerability of Adjunctive Armodafinil in Bipolar I Depression
    Frye, Mark
    Amchin, Jess
    Yang, Ronghua
    Ketter, Terrence
    NEUROPSYCHOPHARMACOLOGY, 2014, 39 : S474 - S475
  • [48] Safety of Bimekizumab in Patients with moderate to severe Psoriasis: Analysis of Pooled Data from Phase II and III Clinical Studies
    Reich, K.
    Blauvelt, A.
    Lebwohl, M.
    Papp, K. A.
    Rich, P.
    Strober, B.
    De Cuyper, D.
    Madden, C.
    Peterson, L.
    Vanvoorden, V.
    Warren, R. B.
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2021, 19 : 64 - 64
  • [49] Safety and Tolerability of Empagliflozin in Patients with Type 2 Diabetes: Pooled Analysis of Phase I–III Clinical Trials
    Sven Kohler
    Cordula Zeller
    Hristo Iliev
    Stefan Kaspers
    Advances in Therapy, 2017, 34 : 1707 - 1726
  • [50] SAFETY PROFILE OF BELATACEPT IN KIDNEY TRANSPLANT RECIPIENTS FROM A POOLED ANALYSIS OF PHASE II AND PHASE III STUDIES
    Grinyo, J.
    Charpentier, B.
    Medina Pestana, J.
    Vanrenterghem, Y.
    Vincenti, F.
    Shi, R.
    Agarwal, M.
    Thomas, D.
    Larsen, C.
    TRANSPLANT INTERNATIONAL, 2010, 23 : 59 - 60
12345